Podcasts about healthtech

In this episode, we chat with Dr. Robert Karanja, co-founder and Chief Innovation Officer of Villgro Africa. As an early-stage investor, the Villgro model comprises a venture capital arm that deploys blended finance (grant/equity) coupled with a bespoke incubation program for a portfolio of startups in the health and life sciences sector. For more information, please visit: https://villgroafrica.org/ MedxTek Africa is produced and hosted by ⁠Dr. Sam Oti⁠, and co-edited by ⁠Veronica Ojiambo⁠. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

"Healthcare is not simply a void which was just waiting for tech to fill in and solve all of its problems."In this podcast episode, Owen Tripp, Founder and CEO of Included Health, shares his thoughts on digital health. We discuss how the space has changed in the last decade and where he thinks we'll be in 10 years, if big tech can really change healthcare, if virtual care matters or more less than it did a few years ago, the troubling M&A of incumbents, and much, much more.Follow guest Owen Tripp on X.Learn more about Included Health.Follow host Halle Tecco on X.Visit the Heart of Healthcare website for episode recaps.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Medsider Radio, we sat down with Deanne McCarthy, founder and CEO of Swiftsure Innovations, a company developing a device capable of safely and effectively cleaning the oral cavity of patients on life support. Deanne was a critical care nurse before she decided to make the switch to medtech entrepreneur. With Deanne's commitment to empowering nurses and enhancing patient outcomes, Swiftsure has assembled an adept team and a robust group of advisors that has enabled the company to move incredibly quickly across key functions like product development, regulatory affairs, and commercialization. In this interview, we explore the invaluable role of mentors and connections in Deanne's journey, her insights on accelerator programs, and how her initial lack of startup experience gave her the tenacity to seek out and validate collaborative partners.  Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Deanne McCarthy.

SD228 - Healthtech de saúde do Brasil para o mundo. Neste podcast, Dr. Lorenzo Tomé conversa com o CEO da epHealth, Pedro Marton Pereira, sobre atenção primária no Brasil e no mundo, acesso a serviços básicos de saúde, o case de sucesso no Brasil e a tecnologia que faz a diferença. A epHealth oferece um aplicativo para coleta de dados da atenção básica para agentes comunitários de saúde e, em parceria com Institutos de Pesquisa, ajuda a desenvolver estudos científicos.  Hoje a empresa também atua no Reino Unido. Participe das nossas comunidades médicas! Para web, acesse AQUI. Baixe nosso app: Android ou IOS Neste episódio, o que você vai encontrar: O Background do Pedro Ele é pós-graduado em Ciências de Dados e Informática para a saúde e especialização em Criação e Gestão de Marcas. Pedro tem formação na UFSC em Administração de Empresas e desde 2011 trabalha com tecnologia para a área da saúde, iniciando com a saúde pública. Foi em campo, em um trabalho de consultoria junto a agentes comunitários, que ele percebeu o tamanho do desafio de levar acesso ao serviço básico de saúde para milhões de pessoas e dedicou-se a buscar uma solução. Comunidade Online Saúde Digital Podcast Você é médico? Quer interagir com o Lorenzo Tomé e com outros colegas inovadores da medicina digital?  Entre na Comunidade do Podcast Saúde Digital na SD Conecta! Assista este episódio também em vídeo no YouTube no nosso canal Saúde Digital Ecossistema! ACESSE AQUI!   Episódios Anteriores - Acesse! SD227 – Gestão de risco populacional SD226 - Blockchain: Protocolo da confiança SD225 - Controle de doenças crônicas na palma da mão Músicas: | Declan DP – Fantasy | Declan DP – Echo | Declan DP - Climb "Music © Copyright Declan DP 2018 - Present. https://license.declandp.info | License ID: DDP1590665"

Another year of exciting developments in the area of digital health and healthcare tech. In this episode, I review some of the health tech trends to watch for in 2024 and beyond! Resources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559147/ https://www.forbes.com/sites/forbestechcouncil/2023/06/01/augmented-reality-is-already-changing-healthcare-for-the-better/?sh=2daf45977851 https://pubmed.ncbi.nlm.nih.gov/33377137/ https://syneoshealthcommunications.com/blog/smart-socks-predict-foot-ulcers-in-diabetic-patients https://techcrunch.com/2016/10/17/targeting-the-untapped-market-of-wearables-for-elder-care/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924773/ Welcome to the Health Analytic Insights Podcast. This podcast is ALL about creating a community of like-minded individuals who are passionate about the field of health informatics. I hope to share information and advice in topics such as health analytics, digital health, biomedical engineering and data visualization in healthcare and in exchange I would love to hear from you DEAR listener about your experience and interest in this field, you can drop me a line at ⁠⁠⁠⁠⁠healthanalyticinsights@gmail.com⁠⁠⁠⁠⁠. Sign up to the newsletter and get your FREE guide to starting your career in health informatics ⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠. https://mailchi.mp/e4cd52ccaaf5/health-analytic-insights DISCLAIMER: The views expressed on this podcast are my own and do not reflect those of people, organizations or institutions that I might be associated with in a professional capacity, unless explicitly stated. The views expressed by the guests on this show are their own and may or may not reflect those of people, organizations or institutions that I might be associated with in a professional capacity, unless explicitly stated.

In this episode of Medsider Radio, we sat down with Cecile Brosset Dubois, CEO of Sonio, a company dedicated to revolutionizing obstetric ultrasound through AI technology.  Cecile began her career in 2005 at Capgemini, later advancing to Bain & Company. Her strategic insights as Head of Strategy at FSI - Fonds Stratégique d'Investissement - and her pivotal roles at Bpifrance set the stage for Cecile's entrepreneurial journey. At Kamet Ventures, she fully embraced the startup world before eventually co-founding Sonio. In this interview, we touch on her strategic approach to product development, the importance of an in-house regulatory team, her drive for meaningful work, and effective tactics for fundraising. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Cecile Brosset.

Eighth Episode: Systematic Helping Hands: Sarah Spear While parenting her daughter with a developmental disability, Sarah Spear experienced firsthand the difficulty of finding accessible businesses. She learned other families were feeling this pain point, too. Sarah recognized the value in sharing resources and knowledge with one another and Empowered Together was born. Today, Empowered Together's marketplace helps folks discover, connect with, and recommend accessible businesses. Sarah has a history of successfully building ventures, from leading PharmaSecure, a HealthTech company in India, through its Series A funding to being the first Executive Director of the Arch Grants startup competition in St. Louis. Her gift for facilitating community and corporate groups gets people to look at things in a different way, curiously engaging with their world. She brings her experience as an entrepreneur, facilitator, and most important, as a disability advocate to Empowered Together. Please join us for what promises to be a moving conversation. Video Version: https://www.youtube.com/live/TM2n1oVl_jQ?si=IYqG0TL7tM6jhKOj Learn more about Mark here: https://www.youtube.com/channel/UC4cXoftnMYJ7bREYG-K9eng https://www.linkedin.com/company/the-anxious-voyage/about/?viewAsMember=true https://www.facebook.com/profile.php?id=100095313165139 https://www.linkedin.com/in/markobrien/ https://www.facebook.com/MarkNelsonOBrien https://www.facebook.com/MartinTheMarlin/ mark@obriencg.com

In the high-stakes world of health tech, are you leading the charge or lost at a crossroads? With the industry on track for a $280 billion breakthrough, it's time to ask: What's holding back your venture's next quantum leap? Too many founders face a growth plateau, where big ideas stall and profits falter. This moment is more than a challenge; it's an opportunity to redefine healthcare's future. Dive in as we chart a course from the status quo to new heights of innovation and market dominance, turning today's potential into your enterprise's powerhouse success. Tune in to turn today's potential into tomorrow's success. What you'll learn from this episode: Unpacking the Plateau: Exploring the common experience of health tech founders facing growth plateaus and the potential for turning them into pivotal opportunities. From Plateau to Peak Performance: Highlighting the significance of continuous innovation beyond product launch to drive revenue growth through a suite of solutions. Decoding the Direction Dilemma: Addressing the challenges of selecting the right strategic path in the health tech industry and the necessity of a specialized, tailored strategy. Dealmaker or Dealbreaker: Delving into the intricacies of closing significant deals in health tech, focusing on precision and strategic positioning. Profit Margins: The Health Tech Vital Signs: Discussing the role of profit margins as critical indicators of business health in health tech and strategies for enhancing them. Expert Advice: Navigating with Experience: Emphasizing the value of experience-based guidance in navigating healthcare regulations, technology trends, and market dynamics. Networking: The Key to Growth: Stressing the importance of building a strong network in healthcare technology for achieving success. Customized Strategies: Tailoring for Breakthroughs: Highlighting the need to customize growth strategies to the unique characteristics of each health tech company, encompassing scaling, compliance, and company culture. Episode Timeline: 00:01:33 - Unpack the Plateau  00:03:09 - From Plateau to Peak Performance  00:06:12 - Decoding and Directing Dilemma  00:08:16 - Deal Maker or Deal Breaker 00:11:32  - The Catalyst for Founders 00:13:33 - The Natural Network of Growth 00:15:12 - The Blueprint for Breakthrough 00:18:08 - The significance of overcoming a growth plateau in health tech  00:18:15 - Key metrics to focus on for improving profit margin in health tech  Join us to learn how these evolving dynamics can shape a more inclusive, innovative, and successful business landscape. Listen to this episode now and Subscribe to the Provider's Edge to never miss an episode SabrinaRunbeck.com/Podcast Or read our weekly newsletter on LinkedIn Stay Tuned, Stay Successful! We love to hear your feedback. Send me your stories or questions on Linkedin.com/in/SabrinaRunbeck

In this episode of Medsider Radio, we had a chat with Tyler Melton, the co-founder and CEO of Corveus Medical, a Houston-based startup on a mission to redefine heart failure treatment. Tyler previously worked at Accenture, consulting for top-tier pharmaceutical companies, and at the J&J Center for Device Innovation, where he honed his skills in strategic planning and financial modeling. He then joined the Texas Medical Center Biodesign Program, where he uncovered his current mission: to treat heart failure with targeted nerve ablation. In this interview, Tyler shares how using off-the-shelf products for early prototypes saved him both time and money and how accelerator programs provided the networking boost his startup needed to tackle the demanding PMA regulatory pathway. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tyler Melton.

Tonix Pharmaceuticals CEO Dr. Seth Lederman recently joined Steve Darling from Proactive to shed light on the latest developments in their research efforts. The company has successfully concluded the clinical phase of a Phase 3 registration-quality study for TNX-102 SL, a drug developed for the management of fibromyalgia. This study, which is double-blind and placebo-controlled, saw the enrollment of 457 patients across various sites in the United States. Lederman conveyed to Proactive that the topline results from this study are anticipated by late December. Should the results be favorable, this trial is expected to be the conclusive well-controlled efficacy trial needed for the submission of a New Drug Application to the U.S. Food and Drug Administration. The urgency and importance of this development are underscored by the fact that an estimated 6-12 million individuals in the U.S. are afflicted with fibromyalgia, a condition that predominantly affects women. In addition to the TNX-102 study, Lederman also discussed another significant milestone: the enrollment of the first participant in a Phase 2 study, supported by the Department of Defense, focusing on TNX-1900 for the improvement of bone health in children with autism spectrum disorder. This investigator-initiated trial represents a foray into addressing the complex needs of children with autism, potentially offering a new therapeutic avenue to enhance their quality of life. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #FibromyalgiaTreatment, #TNX102, #MedicalBreakthroughs, #HealthcareInnovation, #ClinicalTrialsUpdate, #AutismResearch, #BoneHealth, #DrugDevelopment, #FDAApprovalProcess, #HealthNews, #MedicalAdvancements, #PharmaceuticalIndustry, #IntranasalOxytocin, #CEOInterview, #MedicalScience, #ResearchUpdate, #HealthTech, #FutureOfMedicine, #DrugDiscovery, #ScienceAndHealth, #ClinicalStudies, #InnovationInMedicine, #MedicalBreakthroughs2023 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Today, we're going on a fascinating exploration with none other than Robb Wolf, a titan in the world of nutrition, fitness, and longevity. Robb, a former research biochemist, is not only a two-time New York Times and Wall Street Journal best-selling author but also a beacon of knowledge in the health and wellness community.Imagine unraveling the secrets of our ancestral diet with "The Paleo Solution," rewiring our appetites with "Wired to Eat," and challenging conventional wisdom about meat consumption with "Sacred Cow." Today, Robb joins us to delve into these captivating topics and more.But that's not all. With a background that spans from consulting for NASA and the Naval Special Warfare Resiliency program to co-founding the revolutionary Healthy Rebellion community, Robb's insights bridge the gap between complex science and practical life-changing advice.As someone who's passionately plant-based, I'm particularly excited to engage in a thought-provoking dialogue with Robb. We'll navigate the nuances of nutrition, the intricacies of individual health and longevity, and even the controversial crossroads where meat-eaters and vegans meet.What does the latest science say about extending our lifespan through diet? How does our gut microbiome play into our mental health? Can technology truly personalize our path to optimal health? And most importantly, how do we embrace resilience as we age? These are just a few of the questions we'll tackle.So, whether you're a long-time listener or joining us for the first time, prepare to be enlightened, challenged, and inspired. Let's not just live longer, but live better. Let's Superhumanize!In this episode with Robb, you'll discover:The Power of Community in Achieving Health GoalsAt 09:40, Robb emphasizes the critical role of community in achieving and maintaining health. This concept extends beyond individual efforts, highlighting the importance of support systems and shared knowledge in fostering lasting health results.Biochemistry's Influence on Nutritional PerspectivesRobb's background in biochemistry, discussed at 16:40, profoundly impacts his approach to nutrition and fitness. This scientific foundation enables him to analyze dietary trends and fitness regimes with a critical, informed eye, leading to more nuanced recommendations.The Importance of Dietary AwarenessTimestamp 29:00 marks a discussion on the crucial role of awareness in our eating habits. Understanding what we consume is not just about maintaining weight but also about ensuring long-term health and longevity.To Supplement or Not to SupplementThe question of supplementing our diets with pills and vitamins arises at 38:20. This topic delves into the balance between getting nutrients from food versus supplements, considering modern lifestyle and dietary limitations.Fecal Transplants and Gut HealthAt 46:30, Robb touches on the controversial yet promising field of fecal transplants, particularly for those dealing with gastrointestinal issues. This segment highlights the emerging understanding of gut health and its systemic impact.Rethinking Meat ConsumptionTimestamp 53:40 brings a crucial message: the issue isn't about consuming more or less meat but focusing on better-quality meat. This perspective addresses the health crisis while considering environmental and ethical implications.Misconceptions Around "Clean" MeatAt 1:02:00, Robb discusses the misconceptions surrounding what is marketed as "clean" meat, urging consumers to be skeptical and well-informed about their meat sources.Educating Consumers on Food ChoicesBy 1:05:00, the conversation shifts to steps consumers can take to educate themselves about their food choices, emphasizing the importance of being informed and proactive.The Avocado ControversySurprisingly,...

This week Mary Ann and Alex covered a host of news events. Here's the rundown:Fintech + AI = ? News that Ramp and Brex are working to lever AI in the wake of reporting that Brex's growth this year on a sequential-quarterly basis slowed had us thinking. Can AI help fintech startups grow more quickly? The fintech sector could use a boon at this juncture, perhaps this is it.Help I drink too much: Alex dug up a recent venture round in the sobriety space. This time it was Sunnyside, which just raised $11.5 million for its subscription service that helps folks cut back on their drinking. We've discussed other players in the space before, including Reframe.What's ahead for the startup M&A market? The Getir-FreshDirect deal had us thinking. Becca Szkutak thinks that it represents the sort of deal that we'll see next year. Even more, we may see more, similar deals next year.Will AI help startups regain their former value? A recent report from Battery Ventures had Alex thinking about how AI-powered automation could help startups spend less as they grow; Rule of 40, here we come!Hormonal health will be is big: The Equity team dug into Allara the other week. Now we're adding ​​Inito, which just raised $6 million, to our list of startups that are building in the hormonal health market. Natasha was right.And that was the show! Next week is a holiday week here in the United States, so expect something special from us next Friday. We'll be on our regular schedule Monday and Wednesday!For episode transcripts and more, head to Equity's Simplecast website.Equity drops at 7 a.m. PT every Monday, Wednesday and Friday, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews foundersand more!

Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery.    Host: Roelof Botha, Sequoia Capital  Featuring: Anne Wojcicki, Richard Scheller  Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Medsider Radio, we sat down with Angus McLachlan, CEO of Liberate Medical, a company pioneering a non-invasive neuromuscular electrical stimulator to prevent muscle weakening in patients who rely on a ventilator to breathe.Angus has a rich academic and professional history that intersects engineering and healthcare. Originating from Scotland, Angus began his academic journey in mechanical engineering at the University of Glasgow. This laid the foundation for his PhD research focused on electrical muscle stimulation for spinal cord injuries. His innovative work gained the attention of Apellis Pharma, leading to a collaboration that propelled the launch of his own company, Liberate Medical.  In this interview, we talk about Angus's do-it-yourself philosophy, how a deep understanding of the technology you're developing gives you leverage across multiple functions, and the nuances of pitching to investors. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Angus McLachlan.

Rebecca is a Co-Founder and General Partner at Canvas Ventures where she leads early-stage investments in Fintech, Healthtech, and AI. Rebecca has been named to the Forbes Midas List five years running, a Woman to Watch: Senior Deal Maker by the Wall Street Journal, and a Top Woman VC by the New York Times. Some of her notable investments include Luminar (NASDAQ: LAZR), Lending Club (NYSE: LC), Practice Fusion (acq Allscripts), Gabi (acq Experian), Check (acq Intuit), RelateIQ (acq Salesforce), CrowdFlower (acq by Appen), Viewics (acq Roche), FutureAdvisor (acq Blackrock), and Figure8 (acq Appen).  Before founding Canvas, Rebecca served as a General Partner at Morgenthaler Ventures. During her time at Morgenthaler, one of her early investments, Doximity (NYSE: DOCS), went public in 2021 and was one of the year's largest IPOs. Before that, she was the VP of NextCard. At NextCard, the first online credit card company, Rebecca helped scale the company from 30 people to 1300 and an IPO.  You can learn more about:  How to invest in the world's changing entrepreneurs   Founding and managing a leading VC firm  How to be a value-adding board member  ===================== YouTube: @GraceGongCEO Newsletter: @SmartVenture LinkedIn: @GraceGong TikTok: @GraceGongCEO IG: @GraceGongCEO Twitter: @GraceGongGG =====================   Join the SVP fam with your host Grace Gong. In each episode, we are going to have conversations with some of the top investors, superstar founders, as well as well-known tech executives in silicon valley. We will have a coffee chat with them to learn their ways of thinking and actionable tips on how to build or invest in a successful company.

Cheryl Cheng, Founder and CEO of Vive Collective, discusses the unique business model of their investment platform, which focuses on digital health and health tech addressing large problems in healthcare, such as chronic conditions and complex workflows. Cheryl emphasizes the need for seamless integration of digital health solutions into existing healthcare systems and the importance of user interface. While excited about the potential of AI and robotics in healthcare, Cheryl highlights the need to include humans in decision-making while leveraging technology to improve access and quality of care. Cheryl explains, "We're excited to have launched this investment platform a couple of years ago, and the thesis behind it is to be very flexible in the type of capital we can deploy in the types of businesses we can invest in and build. However, they all need to stay within digital health and health tech. The idea was to give us the flexibility to add value to companies along their lifecycle. We can be a continuous investor, roll up our sleeves as former operators, and help founders build their businesses and grow organically and inorganically." "I would say, 8 to 10 years, there has been the rise of digital health and health tech, which is more of a hybrid model for incorporating technology to facilitate or augment the delivery of care. As we all know, through COVID and the pandemic, telemedicine took off. And so there's now a new category that didn't exist, say, 20, 30 years ago. There have always been biotech and medical device investors." "There is this, I would say, interdisciplinary investment category that is relatively new. You see a hybrid of traditional healthcare investors moving into it, as well as traditional tech investors moving into it. Our team is unique in that we have previous digital health investing experience and digital health building experience through product manufacturing, etc." #ViveCollective #MedTechInvestment #HealthTechInvestment #HealthTech #DigitalHealth vivecollective.com Download the transcript here

Cheryl Cheng, Founder and CEO of Vive Collective, discusses the unique business model of their investment platform, which focuses on digital health and health tech addressing large problems in healthcare, such as chronic conditions and complex workflows. Cheryl emphasizes the need for seamless integration of digital health solutions into existing healthcare systems and the importance of user interface. While excited about the potential of AI and robotics in healthcare, Cheryl highlights the need to include humans in decision-making while leveraging technology to improve access and quality of care. Cheryl explains, "We're excited to have launched this investment platform a couple of years ago, and the thesis behind it is to be very flexible in the type of capital we can deploy in the types of businesses we can invest in and build. However, they all need to stay within digital health and health tech. The idea was to give us the flexibility to add value to companies along their lifecycle. We can be a continuous investor, roll up our sleeves as former operators, and help founders build their businesses and grow organically and inorganically." "I would say, 8 to 10 years, there has been the rise of digital health and health tech, which is more of a hybrid model for incorporating technology to facilitate or augment the delivery of care. As we all know, through COVID and the pandemic, telemedicine took off. And so there's now a new category that didn't exist, say, 20, 30 years ago. There have always been biotech and medical device investors." "There is this, I would say, interdisciplinary investment category that is relatively new. You see a hybrid of traditional healthcare investors moving into it, as well as traditional tech investors moving into it. Our team is unique in that we have previous digital health investing experience and digital health building experience through product manufacturing, etc." #ViveCollective #MedTechInvestment #HealthTechInvestment #HealthTech #DigitalHealth vivecollective.com Listen to the podcast here

On this episode of Healthcare Market Matrix, John Farkas is joined by Aaron Hillman, advisory board member at Ratio, to discuss the intricacies of marketing products and solutions to healthcare enterprises, specifically with a consultative approach. Throughout the episode, John and Aaron emphasize the importance of getting out into the field to gather intelligence in order to effectively meet the market's unmet needs. And with almost twenty years in the industry, Aaron shares his thoughts on how to assert value propositions through strategic and targeted content.   Show Notes (0:20) Introducing Aaron Hillman (2:39) Unifying Growth Efforts with a Consultative Marketing Approach (8:00) Stewardship as a Consultative Marketer (13:04) Critical Interactions in the Translation Layer (25:13)The Importance of Intelligence Gathering (32:34) Meeting the Needs of the Market (40:56) Asserting Value Propositions through Content (52:28) Closing Thoughts  

Dr. Rachel Draelos is  the Founder and CEO of Cydoc, a health AI startup that generates medical notes from patient intake forms, enabling streamlined appointments and helping doctors save time on notes. Dr. Draelos was the the first person to graduate from Duke University with an M.D. and a Ph.D. in Computer Science. She also holds an M.S. in Computer Science from Duke University and a B.A. in Biological Sciences from Cornell University. Dr. Draelos' research focuses on artificial intelligence methods development for medical applications. She has published across multiple areas of artificial intelligence, including computer vision, natural language processing, explainable AI, and expert systems, and her academic works have been cited over 300 times. Her machine learning models have been applied to medical images, medical notes, EHR data, and genetic data.  Dr. Draelos is also the author of the popular medicine and AI blog Glass Box Medicine.  Some of the topics we discussed were:Registering an entity'The lean startup' methodologyFinding and talking to potential customersBuilding an MVPWriting and filing patentsVarious medical AI research projects she's worked on Cydoc's overall missionAnd more!Learn more about me or schedule a FREE coaching call: https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group: https://www.facebook.com/groups/190596326343825/ Connect with Dr. Draelos: www.cydoc.aiwww.glassboxmedicine.com  (425) 802-0575

More than 40% of Americans have obesity, a number that continues to rise. And despite being a multi-billion dollar business — the weight loss industry just isn't helping people lose weight. Perhaps that's why new GLP-1 medications are getting so much attention.To learn more, I spoke to Sarah Jones Simmer, CEO of Found. With over $130M in venture funding, Found is the largest medically-supported weight care clinic in the country.Join us as we delve into the history of the weight loss industry, and discuss how telehealth (and responsible prescribing) along with new medications, may just be an inflection point.Visit the Heart of Healthcare website for episode recaps and more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, which premiered on 10/31/2023, I talked with Erkeda DeRouen (MD) about her passion for merging the humanistic aspect of medicine with the new field of emerging technology. Erkeda shared her experience working in a healthtech startup company in the early days of telemedicine, going into full time business for herself as a healthcare consultant, and her non-profit leadership role in helping women & non-binary adults learn software development skills. Erkeda and I also talked at length about her thoughts on emerging technology's ability to improve healthcare for all and how she plans to revolutionize health care with community, collaboration, and cybernetics through The Pace Makerz organization. This is a conversation you won't want to miss!   KEEP IN TOUCH

Recorded during the 2023 AAPM Annual Meeting, Shravani Durbhakula, MD, MPH, MBA, and co-host Mustafa Broachwala, DO, navigate this multifaceted topic alongside two esteemed guests: Dan Brounstein, Chief Strategy Officer with Saluda Medical, and Yele Aluko, MD, MBA, Ernst & Young  Americas Chief Medical Officer.In this episode, we explore:Industry Collaboration: A deep dive into the history and current state of the relationships between pain clinicians and the industry, and what firewalls to remain ethicalClinician Transparency: Discussion around potential conflicts of interest and the call for transparency in disclosures not just as conferences but on social media and modern platforms.The Clinician's Value: Understanding why physician input is essential for industry to cater to real-world clinical needs, and how clinicians can contribute ethically.Patient-Centric Outcomes: How does this relationship directly impact patients, and what does it mean for their care and well-being?Challenges on the Horizon: How does industry navigate artificial intelligence in healthcare, cybersecurity, and diversity in clinical trials? 

All Home Care Matters was honored to welcome Tia Newcomer the CEO of CaringBridge as guest to the show. Tia is an experienced board member and health technology leader known for building cultures that create enterprise value through customer experience excellence and purpose driven brands supported by scalable technology platforms. She joined CaringBridge as the CEO in 2021, ensuring all operations contribute toward the CaringBridge vision – a world where no one goes through a health journey alone. Prior to joining CaringBridge, Tia was the Chief Commercial Officer at Generate Life sciences and has spent the last 20 years in executive roles with a foundation in blue chip technology and consumer packaged goods companies. She has led commercial value creation, creating successful go to market strategies in Global Fortune 100, Private Equity and VC backed companies primarily in the Health Tech industry.  In addition to serving on the CaringBridge board of directors, Tia is an independent board member for Inherent BioSciences, a biotechnology company pioneering epigenetic medicine for complex diseases. She also serves on the Advisory Committee for the American Cancer Society National Breast Cancer Roundtable. And is a member of the Dean's Advisory Board for the University of Nebraska-Lincoln College of Journalism and Mass Communications.    About CaringBridge: CaringBridge is a nonprofit, free communication platform for family caregivers and the loved ones they support on a health journey. We make it easy to share updates while organizing and activating a support network. Facing a health challenge is overwhelming, isolating, and lonely. It's not easy to share updates, ask for help, or coordinate care. During these vulnerable times, people need a trusted place to feel comfortable and protected while receiving support from family and friends. CaringBridge believes that healing happens when we're surrounded by loved ones. Since 1997, we've supported people to simplify group communication and share sensitive health information – on a personal CaringBridge page that's free from ads, private, and easy to use.

Welcome back to the fourth episode of L.I.F.T.S., bringing you the latest industry fitness trends and stories hitting the headlines and stirring up some debate.   This week, hosts Matthew Januszek, Co-Founder of Escape Fitness and Mo Iqbal, Founder & CEO of Sweatworks, are joined by industry expert, entrepreneur and Founder of Endorphinz, Mike Hansen to deep dive into the latest fitness news making the headlines.  In today's episode of LIFTS, we're talking about: Beachbody receives notice of NYSE Trading Share Price Listing Rule Non-Compliance F45 files ‘restated' financials reporting a $372M Loss Bhout successful in raising 10 million euros to spread its ultra-smart boxing bag and gamified studio concept Johnson Health Tech launches a digital studio in the UK Escape Fitness partnership with Hyperice  ====================================================== Subscribe to our YouTube channel and turn on your notifications so you never miss a new video when it's published: https://www.youtube.com/user/EscapeFitness Shop gym equipment: https://escapefitness.com/shop View our full catalog:  https://escapefitness.com/support/catalog https://escapefitness.com/support/catalogue  ====================================================== Facebook: https://www.facebook.com/Escapefitness Instagram: https://www.instagram.com/escapefitness Twitter: https://www.twitter.com/escapefitness LinkedIn: https://www.linkedin.com/company/escapefitness/

In this episode of Medsider Radio, we sat down with Kelly Roman, co-founder and CEO of Fisher Wallace, a company spearheading the development of wearable brain stimulation technology aimed at providing relief from depression, anxiety, and insomnia. Kelly is a Harvard graduate with an English major who took an unconventional path to medtech inspired by his experience co-authoring the graphic novel adaptation of Sun Tzu's "The Art of War." He took a career leap from literature and marketing to pioneer a novel approach to the treatment of mental health. In this interview, we delve into what Kelly's learned on his journey, touching on the value of unconventional thinking, the importance of making mental health treatments more accessible and less stigmatized, and the potential of decentralized clinical trials. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kelly Roman.

Pharma & Healthtech partnerships have great potential. But delivering on thesepartnerships brings hurdles and challenges. From misaligned expectations to differences in culture and communication, it can be hard for the two worlds to find effective collaboration. Hear from Ameya Phadke, PhD. Patients Non-Pharma Solutions Leader at Chiesi Pharmaceuticals and Dennis Hermann, Head of Europe at Kaia Health discuss their partnership, as well as Dan Weinstein, Associate Principal at ZS Associates describe broader trends.

How does a physiotherapist who's not "tech-savvy" turn into an health tech entrepreneur and create a product that is used worldwide?! Tune in to find out!Surabhi interviews Maggie Bergeron, a physiotherapist with a drive to improve client care! We chat about the founding story of Embodia, a health tech platform that make it easier for healthcare professionals to schedule, bill, receive payment, chart, send exercises, send education, host a course and more!We discuss:—Maggie's journey as a physiotherapist and the story of how Embodia was founded—How to take risk as an entrepreneur—Build a business the slow way—Embrace change as a profession—Ways to get outside of your comfort zone—How Embodia has evolved—Maggie's fave features on Embodia.✨This episode is sponsored by Embodia https://www.embodiaapp.com/ - use code momstrength to save $20 off your first month's Tier 3 membership.✨Click here to learn more about How I use Embodia as a Pelvic Physiotherapist!.Bio for Maggie Bergeron:Maggie Bergeron is a PT turned tech entrepreneur. 10 years ago she met a chemical engineer turned software developer at a dragon boat practice that changed the trajectory of her career. Like most healthcare professionals, Maggie was not particularly tech savvy, but deeply cared about helping her patients. Over a summer of dragon boat practices, the founding principles of Embodia were formed and in Oct 2014 Embodia was officially 'born' (ie incorporated), and thus began her journey into building, growing, and scaling a health tech company - with many ups, downs, and twists along the way..Connect with Maggie & Important Links:—www.embodiaapp.com —Instagram @embodia @maggiebpt.Connect with Surabhi:—Find Surabhi on Instagram or Facebook @thepassionatephysio—Website: https://www.thepassionatephysio.ca

Brain-computer interfaces allow people with neurological diseases to control external devices, such as a robotic arm, using their minds alone. While the technology has existed for over twenty years, it has only recently moved into mainstream medical practice.  A company called Precision Neuroscience is pioneering this transition. Precision President and Chief Product Officer Craig Mermel understands that commercializing the technology means first making it safe, minimally invasive, and adaptable to fit the varying needs of neurological patients.  From engineering the first-ever Apple Watch to conducting digital pathology research at Google, Craig has always favored the intersection of technology and healthcare. He's with us today to discuss his journey into Healthtech and the life-changing medical devices he's since created.  Do you have any thoughts? Please email us at hello@rosenmaninstitute.org. We post new episodes every Monday. “The Health Technology Podcast” is produced by Herminio Neto, hosted by Christine Winoto, and engineered by Andrew John Rojek

The healthcare industry has made significant strides in the past 50 years… or has it? In this episode, we sit down with Adrian Aoun, CEO of Forward, an AI-based healthcare system, who is simply not impressed with the lethargic pace of progress. We discuss how artificial intelligence (AI) can help us achieve exponential improvements to human health and how ChatGPT is the worst of the new world.Follow guest Adrian Aoun on Twitter.Follow host Halle Tecco on Twitter.Visit the Heart of Healthcare website for episode recaps and more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Prompted by a diagnosis of multiple sclerosis in 2019, Dr. Omolara transitioned from her career as a professor, researcher & pediatrician to co-founder of Strong Children Wellness — a multi-practice healthcare network that partners with communities to provide tech-enabled physical health, mental health, and social care for Medicaid-eligible & uninsured children and families, including those impacted by poverty, trauma and immigration inequities. As a social entrepreneur, she has secured over $1,000,000 in funding in less than 2 years, without loans or investors. This prompted her to create Melanin & Medicine, a healthcare consulting firm that supports mission-driven healthcare organizations serving communities of color to secure grants, contracts & alternative payments to help them scale and make greater impact.   Dr. Uwemedimo is a noted speaker on social entrepreneurship, funding strategies in healthcare, community-based healthcare for under-resourced communities and clinical & advocacy approaches to supporting anti-poverty health policies, including access to safety net programs, such as Medicaid, SNAP & TANF. She has been an invited speaker for several conferences & organizations including American Academy of Pediatrics, American Women's Medical Association, Health Tech 4 Medicaid, Center for Law and Social Policy, Immigration Advocates Network, United Hospital Fund & Greater NY Hospital Association.

In this episode of Medsider Radio, we had a chat with Dr. Alberto Rodriguez-Navarro, CEO of Levita Magnetics, a startup aiming to make surgical procedures as minimally invasive as possible with its advanced magnetic technology. Dr. Rodriguez-Navarro is not only a skilled surgeon but a medtech visionary with multiple patents to his name. Discover Alberto's journey spanning his childhood fascination with using magnets to clean the inside of his turtle tank to leveraging this concept into a cutting-edge magnetic surgery platform.  In this interview,  Dr. Rodriguez-Navarro discusses what to consider when starting a new business, how to hone your framework when transitioning from the clinic, and early-stage strategies to ease the road to FDA approval. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dr. Rodriguez-Navarro.

We're talking about the week's biggest startup and tech news with Mary Ann, Becca, and Alex. Here's what we got into:What happened to WeWork? As the shared office space company struggles to stay alive, we had a lot to say.Deals of the Week: Mary Ann wanted to chat about Charlie, which is building a neobank for seniors; Alex wanted to talk about an interesting non-profit-ish model to get startups and others access to H100s; Becca brought Almouneer to the table, an interesting healthtech play in the Middle East.From there we dug into massive fintech rounds, which are seemingly back. For more, you can read up on QI Tech, Tabby, and Next Insurance.And, finally, what to do when founding teams break up? Becca has notes.As always, Equity is back for you on Monday, but you can catch up with us in the meantime on X and Threads @EquityPod. Talk soon!For episode transcripts and more, head to Equity's Simplecast website.Equity drops at 7 a.m. PT every Monday, Wednesday and Friday, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews foundersand more!

Olive AI fell off the map yesterday. Today we explore.

Dr. Quyen Ngo: Evaluating the Science Behind Digital Health Tech How do you interrogate the research behind digital health solutions to determine if they are effective, equitable, and ethical? Quyen Ngo, PhD, leads Hazelden Betty Ford's Butler Center for Research. She joins host Chris Hemphill to discuss. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Medsider Radio, we sat down with Bill Colone, the CEO and Chairman of SinglePass, a company developing an electrocautery device for deep tissue biopsies.Bill previously headed Spinal Singularity, raising over $11 million for product and clinical development. He was VP of R&D at Direct Flow Medical and the President of Endomed, which was sold in 2005. Bill also served in multiple leadership roles at Endologix and holds 13 U.S. patents with more pending. He earned his bachelor's in Chemical Engineering from Arizona State University, where he later served as an Associate Faculty Member and sits on the advisory committee for Chemical and Materials Engineering.In this interview, Bill shares invaluable insights and actionable strategies for building and leveraging an expansive network, optimizing fundraising, and strategically planning for both acquisition and independent growth. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Bill Colone.

Today, we're navigating a topic that's crucial for all you innovators, especially in the health tech sphere: The Platform Dilemma. Yes, we're talking about Podcasts, Radio, TV, or Print Media and figuring out what's right for your unique health tech story. We dissected the intricate world of media platforms, analyzing the pros and cons of podcasts, radio, TV, and print media for your health tech story. As we unravel these threads, we also introduce a golden opportunity. What You'll Learn: The strengths and limitations of different media platforms and how to leverage them effectively. Insights into the world of PR: tackling pitches, understanding costs, and the value of professional help versus in-house efforts. Exclusive details about the PulsePoint Path Impact Awards: a chance to catapult your health tech innovation into the limelight across multiple media, free of charge! Special Opportunity: Ready to amplify your health tech story? The PulsePoint Path Impact Awards are your springboard to comprehensive media exposure and recognition in the healthcare industry. Winners receive the unique benefit of featured spots in podcasts, radio shows, TV segments, and print media. Don't miss this chance to showcase your innovation on a grand scale. Apply now at ➡️PulsePointPath.com/Awards. Don't let your innovation go unnoticed. Dive into this episode to master your media strategy and seize your spot in the PulsePoint Path Impact Awards. Your story deserves to be told. Make it heard. Episode Timeline: [00:01:22] - PulsePoint Impact Path Awards [00:08:03] - The cost of podcasting  [00:12:37] - The three natural languages [00:14:26] - Leveraging marketing resources for success [00:18:45] - The power of print medi [00:24:31] - Impact Awards for healthcare solutions [00:27:38] - Prestige and marketing expense [00:33:23] - Scaling your healthcare company Tweets "Choosing the right media platform for your healthcare technology solutions can be a game-changer. Learn how to navigate the podcast, radio, TV, and print media landscape in this episode of The Provider's Edge. #healthtech #mediastrategy" "Are you ready to take your healthcare startup to the next level? Discover the power of podcasting, radio, TV, and print media in amplifying your message and reaching your target audience. Tune in to The Provider's Edge for expert insights. #healthcareinnovation #mediamarketing" "Looking to make a positive social impact with your healthcare technology solution? Find out how to choose the right media platform and create a compelling narrative in this episode of The Provider's Edge. #healthtech #mediastrategy" "Attention healthcare entrepreneurs! Learn how to stand out in a crowded media landscape and connect with your target audience through podcasting, radio, TV, and print media. Don't miss this episode of The Provider's Edge. #healthcaremarketing #mediatips" "Ready to rewrite the rules for your healthcare business? Discover the power of podcasting, radio, TV, and print media in scaling your health tech solution. Join us on The Provider's Edge for expert advice. #healthtech #mediastrategy" ‌Links: http://PulsePointPath.com/Awards Ready to magnify your HealthTech journey's impact? Tune in

In this episode of the Ketones and Coffee Podcast, we are joined by a remarkable guest, David Wong. David is a bestselling author, a visionary inventor, a martial artist, and a Qi Gong practitioner. His journey has taken him to the forefront of cutting-edge technologies for personal wellness.David is the founder of Qi Life, a pioneering health tech company known for its innovative frequency-based devices.But David's vision extends far beyond just business success. He is also the founder of the Qi Life Foundation, a charitable organization with a mission close to his heart. This foundation is dedicated to researching mental health for both children and adults, seeking innovative ways to improve the well-being of those facing mental health challenges.On this Episode: Introduction to David Wong1:57 David Wong's Journey to Recovery through Meditation and Frequencies5:15 PMF (Pulsed Electromagnetic Field) therapy with rife therapy8:10 Uniting Ancient Wisdom with Modern Technology for Healing21:01 Transformative Frequencies: Changing Lives and Healing Trauma27:22 David's Mission to reverse the negative health trends globallyFollow Ketones and Coffee PodcastCall to action for listeners: Follow ketones and Coffee Podcast on Instagram ( https://www.instagram.com/keton.esncoffee ), Youtube ( https://www.youtube.com/channel/UCsZZmBEenvZnU8tA1npAODA ), and Lorenz (  https://www.instagram.com/ketocoachlorenz ) for updates and new episodes.~~~~~~Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.~~~~~~ Save yourself that trip to the market — Instacart delivers groceries in as fast as 1 hour! They connect you with Personal Shoppers in your area to shop and deliver groceries from your favorite stores.Instacart - Groceries delivered in as little as 1 hour. Free delivery on your first order over $35. Go to ketocoachlorenz.com and use the contact form to get your Free Consultation!Support the show

Rebecca Lynn of Canvas Ventures joins Nate to discuss Why Good Marketing Beats Good Product, Emerging Use Cases for AI, and Tactical Advice for Founder to Build Their GTM. In this episode we cover: Product Market Fit, Customer Needs, Marketing Strategies and Product Development Marketing Strategies for Early-Stage Founders Venture Capital, Marketing, and Scalability Investing in Health Tech and Fintech Companies AI in Legal Tech and Debt Collection Guest Links: Twitter LinkedIn Canvas Ventures The hosts of The Full Ratchet are Nick Moran and Nate Pierotti of New Stack Ventures, a venture capital firm committed to investing in founders outside of the Bay Area. Want to keep up to date with The Full Ratchet? Follow us on social. You can learn more about New Stack Ventures by visiting our LinkedIn and Twitter. Are you a founder looking for your next investor? Visit our free tool VC-Rank and we'll send a list of potential investors right to your inbox!

In this episode, guests Sofia Guerra and Steve Kraus from Bessemer Venture Partners discuss their recently published report, "State of Health Tech 2023." We discuss what's going on in the public markets (and why), bad bubbles vs. okay bubbles, how health tech companies compare to other sectors, and looking for phoenixes to rise from the ashes.Read the BVP report here.Read the article on publicly traded digital health companies here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

October 20, 2023: Marty Paslick, Chief Information Officer at HCA Healthcare, delves deep into the communal and technological aspects of health IT. They discuss the transformation of IT from a support role to a central strategic partner in health care, as well as the potential pros and cons of this shift. From the deployment of other industries technologies to improve patient care to reducing nurses' administrative burdens Paslick offers enlightening insights. We also learn about their approach to maintaining culture in a large organization and employee engagement strategies. Finally, Bill and Marty also share their past work in programming and the passion they have for the field. Is the ever-evolving nature of technology a challenge or an opportunity for tomorrow's healthcare?Key Points:Global Tech PartnershipsOrganizational Culture MaintenanceEmployee Engagement StrategiesFuture Healthcare PredictionsRelating and Bonding With StaffJoin us for our webinar "Interoperability Outcomes: A Discussion of What's Possible" on October 5th at 1 PM ET/10 AM PT, discussing challenges in healthcare interoperability. We'll tackle key issues like fragmented technology systems, data privacy, and cost-effectiveness. Engage with top-tier experts to understand the current landscape of healthcare IT, learn data-driven strategies for patient-centered care, and discover best practices for ensuring system security and stakeholder trust. Register Here

In this episode of Medsider Radio, we sat down with Shyam Natarajan, founder and CEO of Avenda Health, which utilizes artificial intelligence and cutting-edge imaging to improve the diagnosis and treatment of prostate cancer.After getting his PhD in Biomedical Engineering from UCLA, Shyam worked as a postdoctoral scholar in UCLA's Department of Surgery, focusing on minimally invasive surgical interventions. He also managed the UCLA Business of Science Center, spearheading initiatives to guide students toward non-academic career paths. With experiences like founding UCLA Innovation Week and the Inventathon, he is committed to pushing the boundaries of medical technology. At Avenda Health, Shyam is now leading the charge in revolutionizing prostate cancer care. In this interview, we talk about what it really takes to understand the market need for your product or service, how prototypes can be incredibly helpful in convincing relevant parties, how Shyam approaches fundraising, and what to expect from medtech in the future given current technological advancements in growing fields like AI. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Shyam Natarajan.

This weeks podcast chat is with CiCi Bellis, Former Professional Tennis Player & Managing Partner at Cartan Capital   You will learn: How to deal with pressure in sports & business The skills to work in the VC Industry How to do a career transition in sports into business This is a must listen to learn how to work in VC in the sports industry!   Let's Connect! Connect with Ed on LinkedIn: https://www.linkedin.com/in/edbowers101/   Follow Ed on Instagram:  https://www.instagram.com/edbowers101/

Welcome back to Common Sense Medicine! For the post, skip down ~2 scrollsLong time, no see, you say. Well, that's true. I've been busy and not-so-busy these past few years, and the long overdue post about “where have you been, Shree?” is coming—I promise. But first, a reflection. Since 2018, when I started this show, the world of healthcare, and my own perspective about it, has changed tremendously. However, there is one constant: talking to people who are “in the weeds” (to borrow a corporate phrase) of the work is the best way to get up to speed in the space. There is so much happening in the world of healthcare like Generative AI, electronic health records, and biotech, and I want to write more about all of it. As I'm in a more “chill” part of medical school, I've been taking the time to talk to founders of interesting HealthTech startups to build a framework about where the industry is headed.When can I expect more posts?, you say. First of all, I'm not sure anyone is asking for more emails in their mailbox, but I hope that if you're subscribed, I'm providing some value. I'm not trying to clutter your email—I think there's a space for interesting conversations about healthcare around 1 time a month. Plus, most people just skim anyway so I'll try and keep the show notes and insights on the shorter side. Alright, now that I've gotten the niceties over with, here are the show notes.Forwarded this email? Subscribe below for musings about healthcare conversations with people who are much smarter than me.What is Anja Health? Anja Health is a health and technology company that provides cord blood, cord tissue, and placenta banking. They are one of the few companies in the world that offer these services. Anja Health's services include: * Freezing umbilical cord and placenta stem cells* Sending a kit to soon-to-be parents in preparation for their birth experience* Safely collecting and storing your baby's stem cells for future cell treatments* Providing an easy to use collection kit with FDA-approved materials* Manual lab processing for maximum stem cell volume* 20 years of secure cryogenic storage at -180°C* Personal support from a banking or birth expertAnja Health's mission is to create one more treatment option through the power of stem cells. Anja Health was founded by Kathryn Cross, just over a year after graduating from Wellesley. Kathryn shared her personal story of founding the company in memory of her brother Andrew, who was diagnosed with cerebral palsy after a near-death accident with me on Common Sense Medicine, and below is a summary of our conversation. Show Notes (with timestamps)* [00:02:18] Cord blood stem cell space.* Kathryn talks about a Duke University study which was a randomized, double-blind crossover trial on cerebral palsy (CP) treatment with autologous cord blood (CB). It didn't show statistically significant results between the study and control groups, but a significant difference was found between the group that received infusions with a higher dose of (>2.5 * 10^7 cells) versus those who did not. * Providers historically have not been educated about giving information about cord blood banking, and social media is easier to go direct to the customer to educate them about the cord blood banking. She spoke about creator-led businesses, which have greater trust (especially in the beginning) when they have relatability and value capture on their side. This was the enabling factor to gaining and acquiring their first few customers. * [00:07:45] Lessons from team members.* She was a younger founder, and she needed to read a lot of material around management to “learn the ropes.” She touches each part of business, but she has been decreasing her involvement with ops to focus on growth and marketing. She tried to find someone who is better than she is at parts of the business, and then aligning with them to achieve the goals which she has for Anja. * [00:11:19] Fundraising process and mistakes.* Kathryn talked about using a process to fundraise for a startup using Ryan Breslow's book Fundraising. He recommends to only fundraise for 3 months, and make sure that you don't fundraise too early before you have product-market fit because the growth will be very painful if so. Kathryn thought that she fundraised too early, and this was partly because she didn't have a process going into her fist fundraising round. * [00:15:17] Private blood banking - why should parents use it? * Kathryn says that most pregnant people should be using cord blood banking because the placenta and the cord blood bank can act as a sort of “insurance” against a worst case scenario. Physicians can use stem cells to prepare treatment and then Anja Health is able to release a patient's units to the provider, and then it's used to give the patient the stem cell treatment. * Shree's take: I'm not convinced that doing this by way of a private blood bank vs. a public blood bank is still reasonable in this day and age, because the cost doesn't justify the evidence which is currently available. If you're bullish on storing on a private blood bank, look for one which is AABB accredited (by the FDA, like Anja is). The one drawback from a public bank which I had noticed is that you might not get your cells if someone else had already used it, but looking at the Duke University study and others in the space, the blood collected might not be useful if you only have one child to do an autologous stem cell transplant—as most of the research is done in preclinical models. However, that's part of Anja's allure, because you might be able to use it in the next 20 years for therapies which haven't been discovered today. * [00:24:24] Using placenta stem cells.* When someone actually donates a blood bank sample, they can increase the density by first sorting it manually. Anja Health mentions that they can do it manually but other companies say that the automatic sorting helps them get rid of contaminants.* Shree's take: I think that this is a function of marketing—if Anja Health is able to capture more of the market and convince their buyers that automatic sorting = bad, and that manual sorting = personalized, then they can effectively control the narrative that their method is better. Kathryn also mentions that she doesn't have any statistics about how many people actually use their stem cells, which gives me pause. How useful could this be if people aren't using it and it's mostly a function of marketing? In fact, one paper shows that automatic sorting actually increases the yield of the cord blood separation. * [00:28:05] Stem cell research in pregnancy.* She's excited about more general parts of women's health related work — infertility and PCOS which came to mind. She also thinks that you shouldn't consume your placenta, ya nasty. * [00:29:24] Scaling content and creator burnout.* It's really hard to scale content because there's a threshold to how much content you can produce. She batches a lot of content, but it's hard to scale them. She had a consigliere who fed her research about content, but now she just does her own thing. She also interviews a lot of people in the space, like doulas, midwives, and lactation consultants. Kathryn thinks that now, she's more able to do speak about her interests “off the cuff” because she's just had so much experience in the space. * [00:34:07] Consuming information and deciphering.* Interestingly she says that lower-income families do a lot more research, read everything, and are more anxious with childbirth rather than those who come from a higher-income family. So, she tries to recommend evidence-based organizations to help families distinguish signal from noise. * [00:36:00] Recruiting. * She's still figuring out how to best recruit, but one of the things that she has to do in order to really put herself in a position for recruiting the best talent is to interview the person and make sure they gel with everyone on the team, whether they have the skills for the particular role that she's hiring for, and gradually hiring into the role (contractor to employee)* Another book from Ryan Breslow which she recommends is Recruiting* [00:45:57] Favorite guest and learning experiences.* Kathryn's question for me! Listen to the podcast to learn more. Thank you for subscribing to Common Sense Medicine! If you have any comments / questions, please reply to this email to let me know what you think. Also, I'm also on the hunt for new podcast guests. If you know anyone who you think would be a good fit (think people in healthtech or healthcare doing interesting, innovative things) feel free to let me know. That's all folks! Remember, it's just common sense. — Shree “I will never eat a placenta” Nadkarni This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.shreenadkarni.com

Remember, you can watch the Superpowers for Good show on e360tv. To watch the episode, download the #e360tv channel app to your streaming device–Roku, AppleTV or AmazonFireTV–or your mobile device. You can even watch it on the web.Devin: What do you see as your superpower?Cyrus: If I had to talk about my superpower, I would say that empathy is my superpower.Quantibly CEO and co-founder Cyrus Z. Kazi is enabling a vital step forward in impact with improved tools for measuring it. I am honored to serve on his advisory board.Born in Bangladesh, he says, “I have seen firsthand what poverty and hunger look like. That helped shape the way I see the world.” He says it prompted him to ask, “Is there anything I can do?” He has devoted his career to making a difference.Quantibly provides tools that seamlessly integrate with existing processes for tracking impact-related activities, allowing more precise calculations of inputs and outcomes. The team built the software around an almost universally accepted framework:There is one framework that almost every organization kind of agrees on, and that is called the theory of change. The theory of change process essentially tracks your resources, looks at the problem, sets certain assumptions, tracks activities and benchmarks, and sees the immediate mid-term and long-term outcomes of the work.With that framework underpinning the Quantibly platform, it is being adopted by a wide range of users, from large corporations to smaller nonprofits.AI Episode SummaryQuantifiable strives to standardize impact reporting for organizations to demonstrate and improve their social impact. Cyrus Kazi's superpower is empathy.* The Superpowers for Good Show is hosting Cyrus Kazi, the CEO and founder of Quantibly, a company that focuses on impact data gathering for nonprofits, social enterprises, and corporate social responsibility departments.* Quantibly is the first platform to collect and report impact data, standardizing the process and making it presentable for stakeholders to see the real impact of their investments.* The platform incorporates an impact framework that tracks resources, benchmarks, and outcomes to provide a holistic view of an organization's impact.* Cyrus has been working with nonprofits, NGOs, governments, and philanthropies for 25 years, leading him to develop Quantibly as a solution for the lack of standardized and verifiable impact data in the sector.* The Quantibly platform simplifies data entry and allows organizations to track outcomes over time, even if the data is collected years later.* The platform also helps foundations and philanthropies monitor the impact of their investments in real time, enabling them to intervene and support grantees as needed.* Quantibly can connect with other data formats, making it easy for organizations to import existing data and avoid double work.* Empathy is Kazi's superpower, which drives his work and motivates him to create value and make a positive impact.* Kazi believes that looking at the world through a value creation lens, rather than a transactional one, enhances empathy and leads to meaningful actions.* Kazi's personal and professional experiences in child welfare influenced his work on Quantibly, as he aimed to use data to protect children from abuse and neglect. How to Develop Empathy As a SuperpowerTo understand the value of empathy, Cyrus explains:We don't live in isolation. Right? So for many, many years, I think either through some philosophical evolution that I had, I started to realize that whatever I am going to do, I can't determine the end result. But as long as my empathy is there, my intentions are there; at least if I can do one good thing for my fellow human beings, I think that will make an impact. So it's a it's a thought process.He helped me see empathy through a more pragmatic lens I'd never considered before. His view of it is that of a visionary CEO. “I don't necessarily think that I look at the world like I used to when I was much younger–from a transactional point of view. I look at it as a value creation point of view. I think that that helps me.”Seeing empathy as a tool for value creation in business akin to strategy is a profound insight for a social entrepreneur.By following Cyrus's example and advice, you can make empathy a practical skill in your portfolio. With practice, you could make it a superpower that enables you to do more good in the world.Guest ProfileCyrus Z. Kazi (he/him):CEO/Co-Founder, QuantiblyAbout Quantibly: Quantibly is the first platform to operationalize impact data collection, analysis, and reporting for the nonprofit, NGO, CSR, philanthropy sector.Website: Quantibly.comTwitter Handle: @quantiblyCompany Facebook Page: facebook.com/quantiblyLinkedin: linkedin.com/company/quantibly  Biographical Information: Since the late 90s, Cyrus has been working with tech companies to drive social impact.He has extensive experience in EdTech, GovTech, HealthTech, and other areas. Hereceived his Bachelor of Arts (BA) in Economics from the Purchase College, SUNY, andholds a Master's in Public Administration (MPA) in Public Policy & Evaluation from MarxeSchool of Public & International Affairs, as well as an Executive MBA) from ZicklinBusiness School, CUNY.Linkedin: linkedin.com/in/cyruskaziSuperpowers for Good is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

This year's Heart of Healthcare $50,000 Grant Challenge winner is the team from the Libertas Center for Human Rights, located at Elmhurst Hospital in Queens, NY.In this episode, we learn about how they provide survivors of torture and human rights violations with comprehensive medical, mental health, social and legal services to help them regain function and restore humanity in their lives.Learn more about support Libertas here.Learn more about the Heart of Healthcare grants here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

310. A Pharmacist's Journey into Health Tech Consulting feat. Pamela Mackey Intended Audience: Everyone In today's episode, we have the distinct pleasure of hosting a thought-provoking interview with Pamela Mackey, a Senior Consultant whose career journey offers a fascinating perspective on the intersection of pharmacy and healthcare technology. With a robust background in pharmacy, Pamela has successfully transitioned into a dynamic role as a senior consultant in the realm of healthcare technology and pharmacy informatics. This conversation delves into her multifaceted career, highlighting her experiences working in various healthcare organizations. Pamela's insights are a treasure trove for anyone interested in a similar career trajectory. She not only sheds light on her professional journey but also shares her perspective on the skills, knowledge, and qualities essential for success in the role of a senior consultant in healthcare technology. For those aspiring to make their mark in this rapidly evolving field, this interview is a beacon of guidance. Pamela's wisdom can serve as a compass, helping individuals navigate the ever-expanding landscape of healthcare technology consulting. Moreover, the episode serves as a valuable resource for healthcare enthusiasts, providing a deeper understanding of the ways technology is reshaping the industry and the career opportunities it presents. If you have any further questions, you can reach out to Pamela on her LinkedIn profile or email via pmackey@hpgresources.com Disclaimer: Views expressed are those of the individuals and do not reflect thoughts and opinions of any entity with which speakers have been, is now, or will be affiliated. New to LinkedIn and not sure where to start? Download my free ebook, "Professional Networking Unlocked", at https://www.tonydaopharmd.com/ebook Follow us on social media! Twitter: @pharmacyitme Instagram: @pharmacyinformatics LinkedIn: https://www.linkedin.com/company/pharmacyitme/ Website: Pharmacy IT & Me Email: tony@pharmacyitme.com Follow Tony's personal Twitter account at @tonydaopharmd Network with other pharmacists at Pharmacists Connect!http://pharmacistsconnect.com For more information on pharmacy informatics, check out some of the following useful links: ASHP's Section of Pharmacy Informatics and Technology: https://www.ashp.org/Pharmacy-Informaticist/Section-of-Pharmacy-Informatics-and-Technology/ HIMSS: https://www.himss.org/resources/pharmacy-informatics-and-its-cross-functional-role-healthcare Disclaimer: Views expressed are my own and do not reflect thoughts and opinions of any entity with which I have been, am now, or will be affiliated.

This week on Rising Giants we have Socheat, the cofounder of one of Cambodia's leading healthteach companies, Pethyoeung, having recently set up their parent company, Pymed, in Dallas, Texas, USA, now entering a period of focused expansion beyond Cambodia. Pethyoeung is the largest cloud-based Hospital Management Software Platform created to advance the healthcare ecosystem in Cambodia and ASEAN nations through securing medical records, patient data and smoothening hospital operating processes and is also integrated with a premier healthcare marketplace to help improving the pathway to access to healthcare of people anywhere, anytime conveniently. Key Points From The Episode: How COVID accelerated healthtech in Cambodia Why unlocking healthcare data is a key driver of future prosperity "Better to die in an ocean than a pond": pushing forward on global expansion Follow RG on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: @risinggiantsfm All RG links: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/risinggiantsfm

In this episode of Medsider Radio, we sat down with Dr. David Albert, founder of AliveCor, which is pioneering the standard for personal ECG devices that extend beyond hardware and encompass services and partnerships to offer comprehensive personal cardiovascular solutions.Dr. Albert is a multifaceted individual — a physician, scientist, inventor, serial entrepreneur, YouTube sensation, and even an adventurous surfer. His academic journey led him from Duke University, where he completed both engineering and medical graduate studies, back to his roots at the University of Oklahoma. He already had several licensed inventions when he decided to stake it all on a new cardiovascular device. The gamble led him to found AliveCor, now a frontrunner in personal electrocardiograms (ECGs) under the renowned Kardia brand. In this interview, we take a tour down the lanes of innovation, prototyping, fundraising, and why sometimes you have to ditch the white coat to take your ideas from the lab to the real world.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dr. Albert.

Subscribe to the Growth Forum Newsletter Click Here

Some clinics have a BMI threshold, which means that women who are considered overweight or obese are often turned away from services without a fair look at their full health.In a world where medical science continually refines its understanding of human physiology, clinging to outdated metrics like BMI as a gatekeeper for reproductive freedom is not merely archaic—it's a negation of evidence-based care. When it comes to the right to preserve fertility, the dimensions of the scale should never outweigh the nuances of individual health and autonomy.Read the full article here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.